Novel Therapeutic Approach for Human T-cell Malignancies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Novel Therapeutic Approach for Human T-cell Malignancies — Stella

Recruiting

Back to T-Cell Leukemia/Lymphoma, Adult trials

Trial locations(2 sites)

Italy

Istituto Nazionale Tumori Fondazione G.Pascale, Naples

Istituto Oncologico Veneto, Padova

Key details

Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

Istituto Nazionale Tumori IRCSS-Fondazione G.Pascale

Enrollment target

~120 participants

Started

July 2024

Primary completion

July 2026

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov